Current Medical Research and Opinion

Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another
pp. 671-682(12)
Authors: Goeree, Ron; Burke, Natasha; O'Reilly, Daria; Manca, Andrea; Blackhouse, Gord; Tarride, Jean-Eric

Comparing the fixed combination brimonidine-timolol versus fixed combination dorzolamide-timolol in patients with elevated intraocular pressure
pp. 683-689(7)
Authors: Arcieri, Enyr S.; Arcieri, Rafael S.; Pereira, Ana C.A.; Andreo, Eduardo G.V.; Finotti, Ioná G.A.; Sá Filho, Wanderley F.

Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation
pp. 691-699(9)
Authors: Kienzle-Horn, Susanne; Vix, Jean-Michel; Schuijt, Chris; Peil, Hubertus; Jordan, Chris C.; Kamm, Michael A.

Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study
pp. 701-711(11)
Authors: Stein, Dan J.; Andersen, Elisabeth Wreford; Tonnoir, Brigitte; Fineberg, Naomi

Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice
pp. 713-719(7)
Authors: Hildemann, Steven K.; Barho, Christian; Karmann, Barbara; Darius, Harald; Bestehorn, Kurt

Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study
pp. 721-730(10)
Authors: Borderias, Luis; Mincewicz, Grzegorz; Paggiaro, Pier Luigi; Guilera, Magda; Sazonov Kocevar, Vasilisa; Taylor, Stephanie D.; Badia, Xavier

Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference
pp. 731-739(9)
Authors: Bjorner, Jakob B.; Wallenstein, Gene V.; Martin, Marie C.; Lin, Peggy; Blaisdell-Gross, Bonnie; Tak Piech, Catherine; Mody, Samir H.

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease
pp. 741-750(10)
Authors: Lew, Mark F.; Pahwa, Rajesh; Leehey, Maureen; Bertoni, John; Kricorian, Greg; The Zydis Selegiline Study Group,

Dihydroergotamine nasal spray for relief of refractory headache: a retrospective chart review
pp. 751-755(5)
Authors: Fisher, Michele; Gosy, Eugene J.; Heary, Blanka; Shaw, Denise

In-hospital treatment of hyperglycemia: effects of intensified subcutaneous insulin treatment
pp. 757-765(9)
Authors: Elinav, Hila; Wolf, Zemira; Szalat, Auryan; Bdolah-Abram, Tali; Glaser, Benjamin; Raz, Itamar; Leibowitz, Gil

Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease
pp. 767-775(9)
Authors: Blagden, M.D.; Chipperfield, R.

Onset of efficacy of tolterodine extended release in patients with overactive bladder
pp. 777-781(5)
Authors: Sussman, David O.; Kraus, Stephen R.; Carlsson, Martin; Guan, Zhonghong

Clinical practice and recent recommendations in hypertension management - reporting a gap in a global survey of 1259 primary care physicians in 17 countries
pp. 783-791(9)
Authors: Bramlage, Peter; Thoenes, Martin; Kirch, Wilhelm; Lenfant, Claude

A double-blind study evaluating the long-term safety of varenicline for smoking cessation
pp. 793-801(9)
Authors: Williams, Kathryn E.; Reeves, Karen R.; Billing, Clare B.; Pennington, Ann M.; Gong, Jason

The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy
pp. 803-810(8)
Authors: Bolge, Susan C.; Mody, Samir; Ambegaonkar, Baishali M.; McDonnell, Diana D.; Zilberberg, Marya D.

Relationship of nasal congestion with sleep, mood, and productivity
pp. 811-819(9)
Authors: Stull, Donald E.; Roberts, Laurie; Frank, Lori; Heithoff, Kim

Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes
pp. 821-831(11)
Authors: Mallett, Veronica; Burks, David; Garely, Alan D.; Smith, Neila

The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program
pp. 833-840(8)
Authors: Piwko, Charles; Ungar, Wendy J.; Einarson, Thomas R.; Wolpin, Jacob; Koren, Gideon

Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea
pp. 841-851(11)
Authors: Ali, Z.; Burnett, I.; Eccles, R.; North, M.; Jawad, M.; Jawad, S.; Clarke, G.; Milsom, I.

The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors
pp. 853-863(11)
Authors: Wang, Junling; White-Means, Shelley I.; Hufstader, Meghan A.; Walker, Genene D.

A retrospective comparison of clinical outcomes and satisfaction using reconstituted recombinant gonadotropins (rFSH) or cartridge rFSH with a pen device in donor oocyte cycles
pp. 865-870(6)
Authors: Christianson, M.S.; Barker, M.A.; Schouweiler, C.; Lindheim, S.R.

Modelling the cost-utility of bio-electric stimulation therapy compared to standard care in the treatment of elderly patients with chronic non-healing wounds in the UK
pp. 871-883(13)
Authors: Clegg, John P.; Guest, Julian F.

Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis
pp. 885-894(10)
Authors: Kastelein, John J.P.; van Leuven, Sander I.; Evans, Gregory W.; Riley, Ward A.; Revkin, James H.; Shear, Charles L.; Bots, Michiel L.; The RADIANCE 1 and 2 Study Investigators,

An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK
pp. 895-901(7)
Authors: Palmer, Andrew J.; Valentine, William J.; Ray, Joshua A.; Foos, Volker; Lurati, Francesco; Smith, Inger; Lammert, Morten; Roze, Stéphane

Long-term glycemic control through preserved β-cell function
pp. 904-904(1)
Author: Pratley, Richard E.

Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control
pp. 905-917(13)
Authors: Cohen, Allison; Horton, Edward S.

Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes
pp. 919-931(13)
Authors: Pratley, Richard E.; Salsali, Afshin

Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies
pp. 933-944(12)
Author: Meece, Jerry

Oral antidiabetic agents in type 2 diabetes
pp. 945-952(8)
Author: Levetan, Claresa